Focal Seizures

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-09
Clinical Trial Update: A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy [Phase 1, Phase 2]
NaviFUS Corporation is conducting a Phase 1/2 clinical trial to evaluate the safety, tolerability, and preliminary efficacy of low-intensity…
CLINICAL_TRIALS research · 2026-04-09
Clinical Trial Update: A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy [NA]
A pilot study to evaluate the efficacy and safety of the NaviFUS System Neuromodulating Treatment for patients with drug-resistant epilepsy …
CLINICAL_TRIALS research · 2026-04-06
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures [Phase 1]
This Phase 1 clinical trial is evaluating the efficacy and safety of Cannabidiol Oral Solution for focal seizures and is currently recruitin…
CLINICAL_TRIALS research · 2025-05-31
Clinical Trial Update: Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) [Phase 2, Phase 3]
A double-blind, randomized trial evaluating PRAX-628 for efficacy and safety in adults with focal seizures is currently in Phase 2/3 and act…
CLINICAL_TRIALS research · 2024-07-23
Clinical Trial Update: Thermocoagulation in Drug Resistant Focal Epilepsy [NA]
This ClinicalTrials.gov entry describes a study of thermocoagulation for drug-resistant focal epilepsy; the trial is currently active but no…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.